Free Trial

Qualigen Therapeutics (QLGN) Short Interest Ratio & Short Volume

Qualigen Therapeutics logo
$0.10
0.00 (0.00%)
(As of 11/1/2024 ET)

Qualigen Therapeutics Short Interest Data

Qualigen Therapeutics (QLGN) has a short interest of 110,200 shares, representing 0.45% of the float (the number of shares available for trading by the public). This marks a 1.10% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.2, indicating that it would take 0.2 days of the average trading volume of 8.32 million shares to cover all short positions.

Current Short Interest
110,200 shares
Previous Short Interest
109,000 shares
Change Vs. Previous Month
+1.10%
Dollar Volume Sold Short
$17,951.58
Short Interest Ratio
0.2 Days to Cover
Last Record Date
October 15, 2024
Outstanding Shares
12,300,000 shares
Float Size
24,460,000 shares
Short Percent of Float
0.45%
Today's Trading Volume
2,723,406 shares
Average Trading Volume
8,324,755 shares
Today's Volume Vs. Average
33%
Short Selling Qualigen Therapeutics?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Qualigen Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

QLGN Short Interest Over Time

QLGN Days to Cover Over Time

QLGN Percentage of Float Shorted Over Time

Qualigen Therapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
10/15/2024110,200 shares $17,951.58 +1.1%0.5%0.2 $0.16
9/30/2024109,000 shares $18,584.50 -60.5%0.5%0 $0.17
9/15/2024275,600 shares $45,363.76 -55.1%1.3%0 $0.16
8/31/2024613,400 shares $115,073.84 +84.4%2.4%0 $0.19
8/15/2024332,600 shares $65,522.20 +38.8%2.9%0 $0.20
7/31/2024239,600 shares $53,263.08 -94.2%2.4%0 $0.22
7/15/20244,160,000 shares $1.61 million +627.9%40.9%0.3 $0.39
6/30/2024571,500 shares $98,469.45 +493.5%6.7%0.1 $0.17
6/15/202496,300 shares $19,163.70 +20.7%1.6%0.1 $0.20
5/31/202479,800 shares $21,546.00 +1.7%1.3%0.5 $0.27
5/15/202478,500 shares $24,083.80 +82.1%1.3%0.8 $0.31
4/30/202443,100 shares $12,921.38 -12.8%0.8%0.6 $0.30
4/15/202449,400 shares $15,808.00 -38.2%0.9%0.8 $0.32
3/31/202479,900 shares $31,960.00 +588.8%1.7%1.3 $0.40
3/15/202411,600 shares $4,294.32 +11.5%0.3%0.2 $0.37
2/29/202410,400 shares $4,785.04 -63.5%0.2%0.2 $0.46
2/15/202428,500 shares $13,523.25 -3.1%0.6%0.7 $0.47
1/31/202429,400 shares $15,452.64 -14.5%0.6%1.1 $0.53
1/15/202434,400 shares $17,595.60 +63.8%0.8%1.3 $0.51
12/31/202321,000 shares $11,550.00 -32.7%0.5%0.9 $0.55
12/15/202331,200 shares $18,033.60 -8.0%0.7%1.6 $0.58
11/30/202333,900 shares $25,052.10 -15.9%0.7%2.5 $0.74
11/15/202340,300 shares $28,250.30 +0.8%0.9%2.7 $0.70
10/31/202340,000 shares $31,108.00 +5.5%0.9%2.7 $0.78
10/15/202337,900 shares $35,091.61 -14.5%0.9%1.9 $0.93
9/30/202344,300 shares $44,743.00 +23.1%1.0%1.7 $1.01
9/15/202336,000 shares $37,800.00 +77.3%0.8%1.4 $1.05
8/31/202320,300 shares $21,112.00 -9.8%0.5%0.8 $1.04
8/15/202322,500 shares $24,525.00 -37.0%0.5%0.9 $1.09
7/31/202335,700 shares $40,341.00 +28.4%0.8%1.2 $1.13
7/15/202327,800 shares $30,749.58 -12.3%0.6%1.1 $1.11
6/30/202331,700 shares $28,878.70 +26.3%0.7%1.1 $0.91
6/15/202325,100 shares $24,098.51 -38.6%0.6%0.7 $0.96
5/31/202340,900 shares $37,746.61 +7.4%0.9%0.2 $0.92
5/15/202338,100 shares $38,862.00 -39.9%0.9%0.2 $1.02
4/30/202363,400 shares $59,507.24 -5.4%1.5%0.4 $0.94
4/15/202367,000 shares $63,650.00 -19.2%1.8%0.4 $0.95
3/31/202382,900 shares $76,690.79 +48.8%2.2%0.2 $0.93
3/15/202355,700 shares $56,257.00 -31.0%1.5%0.2 $1.01
2/28/202380,700 shares $92,466.06 +41.6%2.1%0.3 $1.15
625,000% Gain (Ad)

Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.

2/15/202357,000 shares $70,965.00 -17.2%1.5%0.2 $1.25
1/31/202368,800 shares $88,752.00 -61.2%1.8%0.3 $1.29
1/15/2023177,200 shares $237,448.00 +84.8%4.6%0.8 $1.34
12/30/202295,900 shares $123,615.10 No Change2.5%0.5 $1.29
12/15/202295,900 shares $136,178.00 +18.1%2.5%3.7 $1.42
11/30/202281,200 shares $121,597.00 -11.8%2.1%3.1 $1.50
11/15/202292,100 shares $20,308.05 -90.0%N/A4.3 $0.22
10/31/2022916,300 shares $201,586.00 -2.7%N/A4.3 $0.22
10/15/2022941,700 shares $253,128.96 -15.9%N/A4 $0.27
9/30/20221,120,000 shares $299,040.00 +25.5%N/A4.7 $0.27
9/15/2022892,200 shares $291,927.84 -11.7%N/A3.6 $0.33
8/31/20221,010,000 shares $384,406.00 -1.0%N/A4.3 $0.38
8/15/20221,020,000 shares $433,500.00 -8.9%N/A4.5 $0.43
7/31/20221,120,000 shares $469,056.00 -2.6%N/A4.8 $0.42
7/15/20221,150,000 shares $535,670.00 -2.5%N/A5.1 $0.47
6/30/20221,180,000 shares $672,246.00 -9.9%N/A1 $0.57
6/15/20221,310,000 shares $793,467.00 -9.0%N/A1.2 $0.61
5/31/20221,440,000 shares $807,840.00 +2.1%N/A1.3 $0.56
5/15/20221,410,000 shares $751,530.00 +13.7%N/A1.2 $0.53
4/30/20221,240,000 shares $706,800.00 -43.9%N/A1.1 $0.57
4/15/20222,210,000 shares $1.60 million +63.7%N/A1.8 $0.73
3/31/20221,350,000 shares $891,000.00 +3.9%N/A3.9 $0.66
3/15/20221,300,000 shares $741,000.00 -3.7%N/A0.7 $0.57
2/28/20221,350,000 shares $891,000.00 +2.3%N/A0.6 $0.66
2/15/20221,320,000 shares $970,860.00 -7.0%N/A0.2 $0.74
1/31/20221,420,000 shares $1.24 million -7.8%N/A0.2 $0.87
1/15/20221,540,000 shares $1.62 million -36.1%5.8%0.2 $1.05
12/31/20212,410,000 shares $2.58 million +33.9%9.3%0.3 $1.07
12/15/20211,800,000 shares $1.74 million -68.4%6.9%0.2 $0.96
11/30/20215,700,000 shares $8.38 million +258.5%22.1%0.8 $1.47
11/15/20211,590,000 shares $1.70 million -7.0%6.2%0.3 $1.07
10/29/20211,710,000 shares $1.97 million +4.3%6.7%3.8 $1.15
10/15/20211,640,000 shares $1.92 million -0.6%6.4%3.7 $1.17
9/30/20211,650,000 shares $2.15 million -0.6%6.4%3.5 $1.30
9/15/20211,660,000 shares $2.39 million +16.9%6.5%3.3 $1.44
8/31/20211,420,000 shares $2.23 million -18.9%5.5%2.7 $1.57
8/13/20211,750,000 shares $3.12 million -1.1%6.8%5.2 $1.78
7/30/20211,770,000 shares $3.13 million +2.3%6.9%5 $1.77
7/15/20211,730,000 shares $2.92 million +4.2%6.8%3.4 $1.69
6/30/20211,660,000 shares $3.30 million +9.2%6.5%2.7 $1.99
6/15/20211,520,000 shares $3.19 million -16.0%6.0%2.3 $2.10
5/28/20211,810,000 shares $3.46 million +0.6%7.1%2.5 $1.91
5/14/20211,800,000 shares $2.75 million -6.3%7.1%2.1 $1.53
4/30/20211,920,000 shares $4.22 million +7.9%7.5%1.6 $2.20
4/15/20211,780,000 shares $3.65 million No Change6.3%1.1 $2.05
3/31/20211,780,000 shares $4.63 million -11.4%6.2%1.1 $2.60
3/15/20212,010,000 shares $6.69 million +24.8%7.6%1.2 $3.33
2/26/20211,610,000 shares $5.47 million -10.6%6.1%0.8 $3.40
2/12/20211,800,000 shares $6.98 million -9.6%6.8%1 $3.88
1/29/20211,990,000 shares $7.12 million +3.7%7.5%1.2 $3.58
625,000% Gain (Ad)

Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.

1/15/20211,920,000 shares $6.62 million No Change7.3%1.5 $3.45

QLGN Short Interest - Frequently Asked Questions

What is Qualigen Therapeutics' current short interest?

Short interest is the volume of Qualigen Therapeutics shares that have been sold short but have not yet been covered or closed out. As of October 15th, investors have sold 110,200 shares of QLGN short. 0.45% of Qualigen Therapeutics' shares are currently sold short. Learn More on Qualigen Therapeutics' current short interest.

What is a good short interest percentage for Qualigen Therapeutics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.45% of Qualigen Therapeutics' floating shares are currently sold short.

Is Qualigen Therapeutics' short interest increasing or decreasing?

Qualigen Therapeutics saw a increase in short interest during the month of October. As of October 15th, there was short interest totaling 110,200 shares, an increase of 1.1% from the previous total of 109,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Qualigen Therapeutics' float size?

Qualigen Therapeutics currently has issued a total of 12,300,000 shares. Some of Qualigen Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Qualigen Therapeutics currently has a public float of 24,460,000 shares.

How does Qualigen Therapeutics' short interest compare to its competitors?

0.45% of Qualigen Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Qualigen Therapeutics: Genprex, Inc. (3.51%), Exicure, Inc. (2.73%), Hepion Pharmaceuticals, Inc. (0.33%), MyMD Pharmaceuticals, Inc. (11.82%), Pasithea Therapeutics Corp. (2.84%), Artelo Biosciences, Inc. (0.85%), Processa Pharmaceuticals, Inc. (5.66%), Shuttle Pharmaceuticals Holdings, Inc. (1.67%), Sunshine Biopharma, Inc. (16.08%), 180 Life Sciences Corp. (16.06%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.14 billion), AppLovin Co. ($3.15 billion), Paychex, Inc. ($2.69 billion), Nu Holdings Ltd. ($2.48 billion), Cencora, Inc. ($2.24 billion), International Paper ($2.04 billion), Tractor Supply ($1.96 billion), Coinbase Global, Inc. ($1.93 billion), Moderna, Inc. ($1.91 billion), and SoFi Technologies, Inc. ($1.84 billion). View all of the most shorted stocks.

What does it mean to sell short Qualigen Therapeutics stock?

Short selling QLGN is an investing strategy that aims to generate trading profit from Qualigen Therapeutics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Qualigen Therapeutics?

A short squeeze for Qualigen Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of QLGN, which in turn drives the price of the stock up even further.

How often is Qualigen Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including QLGN, twice per month. The most recent reporting period available is October, 15 2024.




This page (NASDAQ:QLGN) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners